ロード中...
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis
BACKGROUND: Expression of matrix metalloproteases 2, 9 and 14 (MMP-2, MMP-9, MMP-14), tissue inhibitors of metalloprotease 1 and 2 (TIMP-1, TIMP-2) and vascular endothelial growth factor A (VEGF-A) is involved in tumor invasion and metastasis via extracellular matrix degradation and angiogenesis. Th...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364527/ https://ncbi.nlm.nih.gov/pubmed/32669083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07150-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|